Entheon Biomedical Corp. (ENTBF)
OTCMKTS · Delayed Price · Currency is USD
0.0690
-0.0110 (-13.75%)
Aug 22, 2025, 4:00 PM EDT
Entheon Biomedical Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
947.57K USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Nov 30, 2024 | - | - | - |
| Nov 30, 2023 | 250.32K | 60.65K | 31.97% |
| Nov 30, 2022 | 189.68K | - | - |
| Nov 30, 2021 | - | - | - |
| Nov 30, 2020 | - | - | - |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Glass House Brands | 221.55M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 105.45M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.09M |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |
Entheon Biomedical News
- 5 months ago - Entheon Announces Change of Directors - Newsfile Corp
- 5 months ago - Entheon Issues Incentive Stock Options - Newsfile Corp
- 5 months ago - Entheon Announces Termination of Mentis AI Agreement - Newsfile Corp
- 7 months ago - Entheon Announces Agreement to Acquire Mentis AI - Newsfile Corp
- 3 years ago - Entheon Announces Closing of Previously Announced Sale of Certain DMT Clinical Assets - Newsfile Corp
- 3 years ago - Entheon Announces Sale of Certain DMT Clinical Assets and Filing of Provisional Novel Compound Patents - Newsfile Corp
- 3 years ago - Entheon Biomedical Announces Non-Brokered Private Placement Financing - Newsfile Corp
- 3 years ago - Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel & New Clinical Research Platform - Newsfile Corp